Use of Sildenafil Citrate in the Management of Unexplained Infertility in Kisangani, Democratic Republic of Congo - Trial PACTR202310849449401
Access comprehensive clinical trial information for PACTR202310849449401 through Pure Global AI's free database. This Phase 3 trial is sponsored by FONDATION DES ANGES and is currently Recruitment Completed. The study focuses on Obstetrics and Gynecology.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Pan Africa Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
FONDATION DES ANGES
University of Kisangani
Timeline & Enrollment
Phase 3
Oct 01, 2021
Jan 01, 1900
Summary
Traditionally, the diagnosis of unexplained infertility is made when the standard aetiological work-up has failed to reveal any abnormality. For this reason, treatment is typically empirical. first line treatment of unexplained infertility includes observation of the expectant state with timed intercourse and life changes, or clomiphene citrate and intra uterine insemination. In Africa, the most infertile couples do not accept to observe the expectant state. This study aims to evaluate the effectiveness and the safety of Clomiphene citrate + Sildenafil citrate compared with Clomiphene citrate + Estradiol valerate in inducing ovulation in congolese patients suffering from unexplained infertility.
ICD-10 Classifications
Data Source
Pan Africa Clinical Trials Registry
PACTR202310849449401
Non-Device Trial